You are here: Home » News-CM » Companies » News
Business Standard

Alembic Pharmaceuticals intimates of successful inspection of its Baroda facility

Capital Market 


Alembic Pharmaceuticals announced that the Company's Bioequivalence facility located at Baroda was inspected by US Food & Drug Administration (FDA) between 6 March 2017 & 10 March 2017, between 13 March 2017 & 17 March 2017 and between 10 April 2017 to 12 April 2017 for a) Bioequivalence Clinical b) Bioequivalence Bioanalytical c) Pharmacovigilance There were no 483s issued by US FDA at the end of the inspection.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, April 17 2017. 12:54 IST